Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard N Chen

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Frontiers in Oncology|June 7, 2014
Clinical characteristics and management of late urinary symptom flare following stereotactic body radiation therapy for prostate cancerJennifer A Woo, Leonard N Chen, Aditi Bhagat, et al.
Radiation Oncology (London, England)|July 25, 2014
Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancerW Tristram Arscott, Leonard N Chen, Nathan Wilson, et al.
Radiation Oncology (London, England)|June 27, 2014
Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancerLeonard N Chen, Simeng Suy, Hongkun Wang, et al.
Frontiers in Oncology|April 16, 2015
Stereotactic Body Radiation Therapy for Prostate Cancer: What is the Appropriate Patient-Reported Outcome for Clinical Trial Design?Jennifer Ai-Lian Woo, Leonard N Chen, Hongkun Wang, et al.
Frontiers in Oncology|May 21, 2016
Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: The Georgetown University ExperienceCatherine Mercado, Marie-Adele Kress, Robyn A Cyr, et al.
Radiation Oncology (London, England)|December 16, 2014
Proctitis following stereotactic body radiation therapy for prostate cancerDaniel Y Joh, Leonard N Chen, Gerald Porter, et al.
Blood Advances|March 14, 2025
Impact of HLA alloimmunization on clinical outcomes of severe aplastic anemia treated with immunosuppressive therapyJibran Durrani, Leonard N Chen, Ruba N Shalhoub, et al.
The Prostate|May 22, 2014
Correlation of HOXD3 promoter hypermethylation with clinical and pathologic features in screening prostate biopsiesLeonard N Chen, Rachel S Rubin, Eugide Othepa, et al.
Plos One|October 30, 2013
MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214Anvesha Srivastava, Helle Goldberger, Alexander Dimtchev, et al.
Radiation Oncology (London, England)|November 5, 2013
Potency preservation following stereotactic body radiation therapy for prostate cancerOlusola Obayomi-Davies, Leonard N Chen, Aditi Bhagat, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|June 7, 2014
Clinical characteristics and management of late urinary symptom flare following stereotactic body radiation therapy for prostate cancerJennifer A Woo, Leonard N Chen, Aditi Bhagat, et al.
Radiation Oncology (London, England)|July 25, 2014
Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancerW Tristram Arscott, Leonard N Chen, Nathan Wilson, et al.
Radiation Oncology (London, England)|June 27, 2014
Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancerLeonard N Chen, Simeng Suy, Hongkun Wang, et al.
Frontiers in Oncology|April 16, 2015
Stereotactic Body Radiation Therapy for Prostate Cancer: What is the Appropriate Patient-Reported Outcome for Clinical Trial Design?Jennifer Ai-Lian Woo, Leonard N Chen, Hongkun Wang, et al.
Frontiers in Oncology|May 21, 2016
Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: The Georgetown University ExperienceCatherine Mercado, Marie-Adele Kress, Robyn A Cyr, et al.
Radiation Oncology (London, England)|December 16, 2014
Proctitis following stereotactic body radiation therapy for prostate cancerDaniel Y Joh, Leonard N Chen, Gerald Porter, et al.
Blood Advances|March 14, 2025
Impact of HLA alloimmunization on clinical outcomes of severe aplastic anemia treated with immunosuppressive therapyJibran Durrani, Leonard N Chen, Ruba N Shalhoub, et al.
The Prostate|May 22, 2014
Correlation of HOXD3 promoter hypermethylation with clinical and pathologic features in screening prostate biopsiesLeonard N Chen, Rachel S Rubin, Eugide Othepa, et al.
Plos One|October 30, 2013
MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214Anvesha Srivastava, Helle Goldberger, Alexander Dimtchev, et al.
Radiation Oncology (London, England)|November 5, 2013
Potency preservation following stereotactic body radiation therapy for prostate cancerOlusola Obayomi-Davies, Leonard N Chen, Aditi Bhagat, et al.
Pageof 4